PUBLISHER: 360iResearch | PRODUCT CODE: 1494672
PUBLISHER: 360iResearch | PRODUCT CODE: 1494672
[187 Pages Report] The Hernia Repair Market size was estimated at USD 4.56 billion in 2023 and expected to reach USD 4.78 billion in 2024, at a CAGR 5.23% to reach USD 6.52 billion by 2030.
Hernia repair refers to a surgical procedure aimed at correcting hernias, which occur when an organ protrudes through a tear in the surrounding muscle or tissue wall. This condition is often corrected through either open surgery or minimally invasive surgeries. The major factors contributing to the expansion of hernia repair procedures include the increasing awareness of the condition, advancements in surgical technologies, and the rising prevalence of obesity, which is a major risk factor for hernias. However, hernia repair procedures are not without their risks, including the risk of infection, recurrence, and, in some cases, chronic pain post-surgery. Addressing these issues requires ongoing research into more advanced surgical techniques, materials, and post-operative care protocols aimed at reducing these risks and enhancing patient recovery. Innovations in mesh materials and techniques, such as the development of bio-absorbable meshes and robot-assisted surgeries, promise to improve outcomes and reduce complications, thus driving further adoption of hernia repair procedures worldwide.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 4.56 billion |
Estimated Year [2024] | USD 4.78 billion |
Forecast Year [2030] | USD 6.52 billion |
CAGR (%) | 5.23% |
Regional Insights
In the Americas, especially the United States, there is a high demand for technologically advanced hernia repair products such as composite meshes and biologic allografts, driven by a strong healthcare infrastructure and substantial investment in R&D. Major companies in this region benefit from robust distribution networks and comprehensive product portfolios. The APAC region is witnessing rapid growth in hernia repair, fueled by increasing awareness about advanced hernia repair options, rising healthcare expenditure, and improving healthcare facilities. However, the market here is more fragmented, with both global players and local companies, leading to a diverse product range and competitive pricing strategies. The EMEA region presents a diverse scenario with advanced markets in Western Europe focusing on innovation and quality, while markets in the Middle East and Africa are more price-sensitive and gradually adopting newer technologies. Regional companies are expanding in the EMEA region, offering a mix of advanced and cost-effective solutions to cater to varied market demands.
Market Insights
The market dynamics represent an ever-changing landscape of the Hernia Repair Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.
FPNV Positioning Matrix
The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Hernia Repair Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Hernia Repair Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Recent Developments
STERIS Expands Healthcare Products Offering with Acquisition of Surgical Instrumentation Assets from Becton, Dickinson and Company for USD 540 Million
STERIS PLC entered into a definitive agreement to acquire surgical and laparoscopic instrumentation and sterilization container assets from Becton, Dickinson, and Company (BD) for a total consideration of USD 540 million. This strategic acquisition encompasses the well-regarded V. Mueller, Snowden-Pencer, and Genesis brands, reinforcing STERIS's position in providing premium surgical instruments and sterilization solutions to healthcare customers. [Published On: 2023-06-20]
US Regulatory Approval Granted for LiquiBandFix8A
Advanced Medical Solutions Group PLC, a significant player in tissue-healing technologies, announces its recent accomplishment of receiving Pre-Market Approval (PMA) from the U.S. Food and Drug Administration (FDA) for LiquiBandFix8. This approval, a pivotal moment for the company, came ahead of the anticipated schedule, just seven months post-submission, signifying a major success for our debut PMA application. This rapid authorization speaks to our application's exceptional quality and highlights the significant advantages LiquiBandFix8 offers patients undergoing hernia surgeries. [Published On: 2023-06-05]
Tissium Raises Euro 50 Million (USD 54 Million) in Series D Funding to Finance its Commercial Launch and Platform Extension
Tissium, an innovative player in biomorphic programmable polymers for tissue reconstruction, secured a euro 50 million (USD 50 million) investment in its Series D financing round. This fundraising achievement aligns with a series of pivotal accomplishments for the company, particularly the progression of its study of COAPTIUM Connect for nerve repair in Australia, alongside various regulatory endeavors. The newly secured funds are instrumental in advancing TISSIUM's strategic milestones, explicitly supporting the commercial launch of its inaugural products in nerve and hernia repair. [Published On: 2023-05-23]
Strategy Analysis & Recommendation
The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Hernia Repair Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.
Key Company Profiles
The report delves into recent significant developments in the Hernia Repair Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Advanced Medical Solutions Limited, Aran Biomedical, B. Braun SE, Baxter International Inc., Becton, Dickinson and Company,, BioCer Entwicklungs-GmbH, Dolphin Sutures, DynaMesh, Herniamesh Srl, Integra LifeSciences Corporation, Johnson & Johnson Services, Inc., Lotus Surgicals Pvt. Ltd., Medtronic PLC, Olimp - Surgical sutures, Orion Sutures India Pvt. Ltd., SERAG-WIESSNER GmbH & Co. KG, Shandong Haidike Medical Products Co., Ltd., Spire Healthcare Group PLC, SUGII SURGICAL INDIA PRIVATE LIMITED, Surgical Sutures Private Limited, TELA Bio, Inc, Unisur Lifecare Private Limited, W. L. Gore & Associates, Inc., and Zhejiang Geyi Medical Instrument Co., Ltd..
Market Segmentation & Coverage